Recent TTOO News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/08/2024 10:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 02:30:28 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/07/2024 02:02:19 AM
- T2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024 • GlobeNewswire Inc. • 11/05/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:59:59 PM
- T2 Biosystems to Host Business Update Call on October 10, 2024 • GlobeNewswire Inc. • 10/08/2024 08:05:00 PM
- T2 Biosystems, Inc. and Prxcision, Inc. Announce Co-Marketing Collaboration for Rapid Direct-From-Blood Diagnostics and AI-Powered Decision Support Platform • GlobeNewswire Inc. • 10/08/2024 01:00:00 PM
- T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens • GlobeNewswire Inc. • 10/07/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 01:00:32 PM
- T2 Biosystems Announces Preliminary Third Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/07/2024 01:00:00 PM
- T2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood Culture • GlobeNewswire Inc. • 09/23/2024 01:00:00 PM
- T2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European Union • GlobeNewswire Inc. • 09/20/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:59:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 01:16:29 PM
- T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients • GlobeNewswire Inc. • 09/16/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 01:10:01 PM
- T2 Biosystems Provides Updates on its New Product Development Pipeline Progress • GlobeNewswire Inc. • 09/09/2024 01:00:00 PM
- T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/27/2024 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/23/2024 08:31:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:49:41 PM
- T2 Biosystems to Attend Upcoming Investor Conferences • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/30/2024 04:15:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 09:00:32 PM
- T2 Biosystems Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/29/2024 08:05:00 PM
- T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor • GlobeNewswire Inc. • 07/29/2024 08:02:00 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM